Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats

Journal of Virology

Volumn 77, Issue 14, 2003, Pages 7830-7842

  Schwantes, Astrid ^a,e   Truyen, Uwe ^b,c   Weikel, Joachim ^c   Weiss, Christian ^d   Löchelt, Martin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Zentralinstitut   (Germany)

^d BAYER AG   (Germany)

^e PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CALICIVIRUS; CAT; CHIMERA; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SPUMA VIRUS; VIRUS CAPSID; VIRUS IMMUNITY; VIRUS INDUCTION; VIRUS REPLICATION; VIRUS SHEDDING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CALICIVIRIDAE INFECTIONS; CALICIVIRUS, FELINE; CAPSID PROTEINS; CAT DISEASES; CATS; CELL LINE; GENETIC VECTORS; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; SPUMAVIRUS; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0038082334     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.14.7830-7842.2003     Document Type: Article

References (42)

1. Alke, A., A. Schwantes, M. Zemba, R. M. Flügel, and M. Löchelt. 2000. Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus. Virology 275:170-176.
2. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
3. Bodem, J., M. Löchelt, H. Delius, and R. M. Flügel. 1998. Detection of subgenomic cDNAs and mapping of feline foamy virus mRNAs reveals complex patterns of transcription. Virology 244:417-426.
4. Bodem, J., M. Löchelt, I. Winkler, R. P. Flower, H. Delius, and R. M. Flügel. 1996. Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J. Virol. 70:9024-9027.
5. Bodem, J., M. Löchelt, P. Yang, and R. M. Flügel. 1997. Regulation of gene expression by human foamy virus and potentials of foamy viral vectors. Stem Cells 15:141-147.
6. Bonnet, M. C., J. Tartaglia, F. Verdier, P. Kourilsky, A. Lindberg, M. Klein, and P. Moingeon. 2000. Recombinant viruses as a tool for therapeutic vaccination against human cancers. Immunol. Lett. 74:11-25.
7. Burton, D. R. 2002. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2:706-713.
8. Enssle, J., I. Jordan, B. Mauer, and A. Rethwilm. 1996. Foamy virus reverse transcriptase is expressed independently from the Gag protein Proc. Natl. Acad. Sci. USA 93:4137-4141.
9. Falcone, V., J. Leupold, J. Clotten, E. Urbanyi, O. Herchenröder, W. Spatz, B. Volk, N. Bohm, A. Toniolo, D. Neumann-Haefelin, and M. Schweizer. 1999. Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257:7-14.
10. Flower, R. L., G. E. Wilcox, R. D. Cook, and T. M. Ellis. 1985. Detection and prevalence of serotypes of feline syncytial spumaviruses. Arch. Virol. 83:53-63.
11. Geissler, K., K. Schneider, G. Platzer, B. Truyen, O. R. Kaaden, and U. Truyen. 1997. Genetic and antigenic heterogeneity among feline calicivirus isolates from distinct disease manifestations. Virus Res. 48:193-206.
12. Geissler, K., K. Schneider, and U. Truyen. 2002. Mapping neutralizing and non-neutralizing epitopes on the capsid protein of feline calicivirus. J. Vet. Med. B Infect. Dis. Vet. Public Health 49:55-60.
13. Hellebrekers, L. J., V. Baumans, A. P. Bertens, and W. Hartman. 1990. On the use of T61 for euthanasia of domestic and laboratory animals: an ethical evaluation. Lab. Anim. 24:200-204.
14. Hill, C. L., P. D. Bieniasz, and M. O. McClure. 1999. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80:2003-2009.
15. Hoover, E. A., and D. E. Kahn. 1975. Experimentally induced feline calicivirus infection: clinical signs and lesions. J. Am. Vet. Med. Assoc. 166:463-468.
16. Linial, M. 2000. Why aren't foamy viruses pathogenic? Trends Microbiol. 8:284-289.
17. Linial, M. L. 1999. Foamy viruses are unconventional retroviruses. J. Virol. 73:1747-1755.
18. Löchelt, M., and R. M. Flügel. 1996. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J. Virol. 70:1033-1040.
19. Löchelt, M., W. Muranyi, and R. M. Flügel. 1993. Human foamy virus genome possesses an internal, Bel-l-dependent and functional promoter. Proc. Natl. Acad. Sci. USA 90:7317-7321.
20. McCabe, V. J., I. Tarpey, and N. Spibey. 2002. Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein. Vaccine 20:2454-2462.
21. Meiering, C. D., and M. L. Linial. 2001. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14:165-176.
22. Milton, I. D., J. Turner, A. Teelan, R. Gaskell, P. C. Turner, and M. J. Carter. 1992. Location of monoclonal antibody binding sites in the capsid protein of feline calicivirus. J. Gen. Virol. 73:2435-2439.
23. Nabel, G. J. 2001. Challenges and opportunities for development of an AIDS vaccine. Nature 410:1002-1007.
24. Neill, J. D., S. V. Sosnovtsev, and K. Y. Green. 2000. Recovery and altered neutralization specificities of chimeric viruses containing capsid protein domain exchanges from antigenically distinct strains of feline calicivirus. J. Virol. 74:1079-1084.
25. Rethwilm, A. 1995. Regulation of foamy virus gene expression. Curr. Top. Microbiol. Immunol. 193:1-24.
26. Russell, D. W., and A. D. Miller. 1996. Foamy virus vectors. J. Virol. 70: 217-222.
27. Santillana-Hayat, M., F. Rozain, P. Bittoun, C. Chopin-Robert, J. Lasneret, J. Peries, and M. Canivet. 1993. Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res. Virol. 144:389-396.
28. Schnell, M. J. 2001. Viral vectors as potential HIV-1 vaccines. FEMS Microbiol. Lett. 200:123-129.
29. Schwantes, A., I. Ortlepp, and M. Löchelt. 2002. Construction and functional characterization of feline foamy virus-based retroviral vectors. Virology 301: 53-63.
30. Seal, B. S., J. F. Ridpath, and W. L. Mengeling. 1993. Analysis of feline calicivirus capsid protein genes: identification of variable antigenic determinant regions of the protein. J. Gen. Virol. 74:2519-2524.
31. Tohya, Y., N. Yokoyama, K. Maeda, Y. Kawaguchi, and T. Mikami. 1997. Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus. J. Gen. Virol. 78:303-305.
32. Truyen, U., K. Geissler, and J. Hirschberger. 1999. Tissue distribution of virus replication in cats experimentally infected with distinct feline calicivirus isolates. Berl. Muench. Tieraerztl. Wochenschr. 112:355-358.
33. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, H. Tamamura, H. Yamagishi, K. Okumura, P. Walden, T. Suto, and T. Kawasaki. 2000. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 51:816-828.
34. Wagner, A., A. Doerks, M. Aboud, A. Alonso, T. Tokino, R. M. Flügel, and M. Löchelt. 2000. Induction of cellular genes is mediated by the Bell transactivator in foamy virus-infected human cells. J. Virol. 74:4441-4447.
35. Winkler, I., J. Bodem, L. Haas, M. Zemba, H. Delius, R. Flower, R. M. Flügel, and M. Löchelt. 1997. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 71:6727-6741.
36. Winkler, I. G., R. M. Flygel, M. Löchelt, and R. L. Flower. 1998. Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats. Virology 247:144-151.
37. Winkler, I. G., M. Löchelt, and R. L. P. Flower. 1999. Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. J. Clin. Microbiol. 37:2848-2851.
38. Yokoyama, N., K. Fujita, A. Damiani, E. Sato, K. Kurosawa, T. Miyazawa, S. Ishiguro, M. Mochizuki, K. Maeda, and T. Mikami. 1998. Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen. J. Vet. Med. Sci. 60:717-723.
39. Yokoyama, N., K. Maeda, K. Fujita, S. Ishiguro, T. Sagawa, M. Mochizuki, Y. Tohya, and T. Mikami. 1996. Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats. Arch. Virol. 141:2339-2351.
40. Yokoyama, N., K. Maeda, Y. Tohya, Y. Kawaguchi, K. Fujita, and T. Mikami. 1996. Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats. Vaccine 14:1657-1663.
41. Yu, S. F., D. N. Baldwin, S. R. Gwynn, S. Yendapalli, and M. L. Linial. 1996. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579-1582.
42. Zemba, M., A. Alke, J. Bodem, I. G. Winkler, R. L. Flower, K. Pfrepper, H. Delius, R. M. Flügel, and M. Löchelt. 2000. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences. Virology 266:150-156.